GUILFORD PHARMACEUTICALS INC 5
5 · GUILFORD PHARMACEUTICALS INC · Filed Feb 12, 2004
Insider Transaction Report
Form 5
KELLY MICHAEL /NMN/
VP, Commercial Operations
Transactions
- Other
Common Stock
2003-06-30$4.46/sh+300$1,338→ 1,961 total(indirect: By 401(k)) - Other
Common Stock
2003-07-31$5.52/sh+392$2,164→ 2,353 total(indirect: By 401(k)) - Other
Common Stock
2003-09-30$6.19/sh+458$2,835→ 2,811 total(indirect: By 401(k)) - Other
Common Stock
2003-12-31$6.78/sh+160$1,085→ 3,540 total(indirect: By 401(k)) - Other
Common Stock
2003-10-31$7.32/sh+350$2,562→ 3,161 total(indirect: By 401(k)) - Other
Common Stock
2003-11-28$6.89/sh+219$1,509→ 3,380 total(indirect: By 401(k)) - Other
Common Stock
2003-05-30$5.58/sh+913$5,095→ 1,661 total(indirect: By 401(k))
Holdings
- 50,000
Stock Options (Right to buy)
Exercise: $4.97From: 2003-12-01Exp: 2012-12-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1) Shares issued to 401(k) plan account of reporting person as part of company match program; amounts vest in participant accounts 25% per year based on years of service with company.